Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging Molecular Dependencies of Mutant EGFR-Driven Non-Small Cell Lung Cancer. | Cells | 2021 | 34944063 | PubTator, text mining | PubMed |
| Reproductive history and blood cell DNA methylation later in life: the Young Finns Study. | Clin Epigenetics | 2021 | 34930449 | PubTator, text mining | PubMed |
| Novel Nanocrystal Injection of Insoluble Drug Anlotinib and Its Antitumor Effects on Hepatocellular Carcinoma. | Front Oncol | 2021 | 34926286 | PubTator, text mining | PubMed |
| Exome-Sequencing Identifies Novel Genes Associated with Recurrent Pregnancy Loss in a Chinese Cohort. | Front Genet | 2021 | 34925444 | PubTator, text mining | PubMed |
| An overview of kinase downregulators and recent advances in discovery approaches. | Signal Transduct Target Ther | 2021 | 34924565 | PubTator, text mining | PubMed |
| Promotion of miR-221-5p on the Sensitivity of Gastric Cancer Cells to Cisplatin and Its Effects on Cell Proliferation and Apoptosis by Regulating DDR1 [Retraction]. | Onco Targets Ther | 2021 | 34916804 | PubTator, text mining | PubMed |
| Breast tissue regeneration is driven by cell-matrix interactions coordinating multi-lineage stem cell differentiation through DDR1. | Nat Commun | 2021 | 34893587 | PubTator, text mining | PubMed |
| A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors. | Molecules | 2021 | 34885957 | PubTator, text mining | PubMed |
| Artificial intelligence: A powerful paradigm for scientific research. | Innovation (Camb) | 2021 | 34877560 | PubTator, text mining | PubMed |
| Identification of Prognostic Biomarkers Originating From the Tumor Stroma of Betel Quid-Associated Oral Cancer Tissues. | Front Oncol | 2021 | 34869001 | PubTator, text mining | PubMed |
| Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer. | Front Pharmacol | 2021 | 34867402 | PubTator, text mining | PubMed |
| A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias. | Front Pharmacol | 2021 | 34867354 | PubTator, text mining | PubMed |
| Genetically Modified T Cells for Esophageal Cancer Therapy: A Promising Clinical Application. | Front Oncol | 2021 | 34858843 | PubTator, text mining | PubMed |
| Mapping the serum proteome to neurological diseases using whole genome sequencing. | Nat Commun | 2021 | 34857772 | PubTator, text mining | PubMed |
| Clusterin suppresses invasion and metastasis of testicular seminoma by upregulating COL15a1. | Mol Ther Nucleic Acids | 2021 | 34853731 | PubTator, text mining | PubMed |
| Molecular targeted therapy for advanced or metastatic soft tissue sarcoma. | Cancer Control | 2021 | 34844463 | PubTator, text mining | PubMed |
| Curcumin derivative ST09 modulates the miR-199a-5p/DDR1 axis and regulates proliferation and migration in ovarian cancer cells. | Sci Rep | 2021 | 34837026 | PubTator, text mining | PubMed |
| Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management. | J Pers Med | 2021 | 34834454 | PubTator, text mining | PubMed |
| Mitochondrial Metabolism in Melanoma. | Cells | 2021 | 34831420 | PubTator, text mining | PubMed |
| Cabozantinib Is Effective in Melanoma Brain Metastasis Cell Lines and Affects Key Signaling Pathways. | Int J Mol Sci | 2021 | 34830178 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=41